| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 124.39M | — |
| Operating expense | — | — |
| Net income | 37.82M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, ADMA returned -45.0% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -46.3% |
| 1 year | -45.0% |
| 5 years | +630.6% |
| 10 years | +71.5% |
| All-time high | $23.80 (Apr 2025) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in ADMA would be worth today ›No. ADMA Biologics, Inc. has not paid a dividend in the past 12 months.
ADMA Biologics, Inc. stock trades on NASDAQ under the ticker symbol ADMA.
ADMA Biologics, Inc. is part of the Healthcare sector.
ADMA Biologics, Inc. has a market cap of 2.19B USD, based on the latest quote.
ADMA Biologics, Inc. is expected to report earnings around Nov 4, 2026. That date is an estimate and has not been confirmed by the company.
